Stage IIB Prostate Cancer Completed Phase 1 Trials for Indocyanine green (DB16024)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02119858Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing SurgeryDiagnostic